RLBD's Kidrin on Revs, M&A, and TPB
Real Brands (OTCQB:RLBD) CEO Thom Kidrin discussed significant company developments in an interview with Capital Gains Report. Key points include anticipation of revenue guidance in Q2 or Q3 2022, ongoing discussions for acquisitions in the CBD beverage sector, and the company's strategic partnership with Turning Point Brands (TPB), which holds a 23% equity stake. Kidrin highlighted an international distribution deal and the firm’s efforts to integrate celebrity marketing. The company also aims to innovate with unique formulations targeting health issues.
- CEO Thom Kidrin anticipates revenue guidance in Q2 or Q3 2022.
- International distribution deal announced, enhancing market reach.
- Exploring acquisitions in CBD beverages, including discussions with two beverage companies.
- Turning Point Brands (TPB) is a 23% equity shareholder, indicating strong backing.
- Delay in production due to COVID impacts, potentially affecting early revenue generation.
- No immediate revenue to show from the international distribution deal.
Capital Gains Report Interviews Real Brands (OTCQB:RLBD) CEO Thom Kidrin
NAPLES, FL / ACCESSWIRE / March 14, 2022 / Capital Gains Report initiated a series of interviews with Real Brands, Inc. (OTCQB:RLBD) CEO Thom Kidrin. In the first discussion, Kidrin spoke about Real Brands' sales, potential acquisitions, and the company's relationship with Turning Point Brands (TPB) among several other topics.
INTERVIEW HIGHLIGHTS
- On revenues- "We should have revenue guidance in Q2 or Q3"
- Acquisitions in CBD Beverage space- "I am speaking to two beverage companies with distribution and production, the products include a non-alcoholic beer, CBD beer, and THC beer."
- Kidrin's Experience- "I was a cofounder of Marimed, we started with a
$10 million dollar market cap and took it to$1.5 billion ." - On Large Cap Shareholder- "Turning Point Brands (TPB) is
23% equity shareholder, we supply CBD to them and are exploring other strategic avenues. I am in close communication with TPB's CEO."
SALES AND DISTRIBUTION
Real Brands just announced an international distribution deal. When asked about the marketing aspect, "They will work with celebrities local to their country, creating an awareness program."
One example of a product fitting a certain region Kidrin pointed out was in Hungary. "If there is one thing Hungary is famous for, it's the country's luxurious thermal baths, there will be an opportunity for distributors to affiliate our cosmetic, or as we call them ‘cosmedic' brands to popular spas."
While the distribution news will take a bit to end up on RLBD's bottom line, we asked what RLBD's current sales project to be.
"Our focus has been on building our facility, which was slowed during COVID, however, finally it is up and running producing our base product."
Due to this delay, Kidrin said the company "Should have revenue guidance in Q2 or Q3 of this year."
The biggest win so far for the company in 2022 has been its uplisting to the OTC QB. "The focus has been on receiving the uplisting, so we can speak to bankers and raise capital to meet the marketing needs to grow our brands."
M&A POTENTIAL
"I am speaking to two beverage companies with distribution and production, the products include a non-alcoholic beer, CBD beer, and THC beer." Kidrin continued to say, "We have interest in either buying the brewery and distribution or the brands and distribution."
"We're also talking to significant principles from a leading new player in the beverage market with high nine-figure revenues about heading up a Real Brands beverage division if we make an acquisition."
Another major factor in Real Brands' M&A potential is its largest shareholder, Turning Point Brands (NYSE: TPB). The company is famous for ZigZag, Stokers, and BeechNut.
Kidrin noted, "Turning Point is
WHY RLBD?
We asked Kidrin why investors should consider RLBD as an investment.
"I was a cofounder of Marimed, we started with a
"We have unique formulations and unique products. We are not a CBD company, that's just an ingredient, we can separate anything at a molecular level."
"Our focus has always been using novel ingredients to solve major health problems such as opioid addiction. To that, we are willing to work with any technology that will get us to that goal. "
"We even have a Metaverse treatment coming soon…"
Stay tuned to Capital Gains Report for the next interview in our series spotlighting Thom Kidrin and Real Brands, Inc. (OTCQB: RLBD).
Disclaimers: Capital Gains Report ‘CGR' is responsible for the production and distribution of this content. CGR is not operated by a licensed broker, a dealer, or a registered investment adviser. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CGR. strongly urges you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. Readers are advised to review SEC periodic reports: Forms 10-Q, 10K, Form 8-K, insider reports, Forms 3, 4, 5 Schedule 13D. For some content, CGR., its authors, contributors, or its agents, may be compensated for preparing research, video graphics, and editorial content. CGR has been compensated fifteen thousand dollars via wire transfer by Washington Capital to produce and syndicate content for RLBD. As part of that content, readers, subscribers, and website viewers, are expected to read the full disclaimers and financial disclosures statement that can be found on our website.
The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quote; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investors investment may be lost or impaired due to the speculative nature of the companies profiled.
To educate and attract more investors contact us at:
Mark McKelvie
editorcapitalgainsreport@gmail.com
(754) 233-0966
SOURCE: Capital Gains Report
View source version on accesswire.com:
https://www.accesswire.com/692447/RLBDs-Kidrin-on-Revs-MA-and-TPB
FAQ
What are Real Brands' revenue expectations for 2022?
What acquisitions is Real Brands considering?
Who is Real Brands' largest shareholder?
What new distribution strategies is Real Brands implementing?
How has COVID affected Real Brands' production?
